- Institut de Recerca Biomèdica de Lleida (IRB-Lleida)
Institut d'investigació
Instituto de Investigación Sanitaria Biodonostia
San Sebastián, EspañaInstituto de Investigación Sanitaria Biodonostia-ko ikertzaileekin lankidetzan egindako argitalpenak (5)
2022
-
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain
Neurologia, Vol. 37, Núm. 8, pp. 615-630
-
Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology
Multiple Sclerosis and Related Disorders, Vol. 63